✦ LIBER ✦

35: High BAFF and BCR-activated B Cells in Patients with Progressive Chronic Graft Versus Host Disease After Rituximab Treatment

✍ Scribed by S. Sarantopoulos; K.E. Stevenson; H.T. Kim; N.S. Bhuiya; C.S. Cutler; E.P. Alyea; V.T. Ho; R.J. Soiffer; J.H. Antin; J. Ritz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Elevated B cell activating factor (BAFF)

✍ S. Sarantopoulos; E. Zorn; N.S. Bhuiya; H.T. Kim; R.J. Soiffer; C.S. Cutler; J. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Treatment of severe neutropenia with hig

✍ Mariam Rauf; Charise Gleason; Ajay K Nooka; Abbie Husman; Edmund K Waller 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 182 KB

Minimal residual disease is common after

✍ Mattsson, J; Uzunel, M; Remberger, M; Ljungman, P; Kimby, E; Ringdén, O; Zetterq 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 167 KB

Association With the Presence of Naive T

✍ B. Wysoczanska; K. Bogunia-Kubik; D. Dlubek; E. Jaskula; A. Sok; D. Drabczak-Skr 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 195 KB